MTOR and cancer: As PP2A works to negatively regulate the mTOR signaling pathway, there are many feedback loops to assist in the further control of this pathway, though it is still frequently deregulated in cancer cells which eventually leads to aberrant cell progression, diminished apoptosis, and increased protein synthesis [42].